编辑推荐——11年间单中心连续收治的136例B型主动脉夹层患者的长期生存与风险分析
该研究回顾性分析了11年间单中心连续收治的136例急性B型主动脉夹层患者的临床与CT影像资料,比较了接受腔内治疗(复杂型)与药物治疗(非复杂型)患者的特征。平均随访51个月(1-132个月),期间发生33例死亡和48例主动脉事件;1年和5年总生存率分别为94.0%和74.8%,无主动脉事件生存率分别为75.6%和58.7%;腔内治疗与单纯药物治疗在1年和5年的全因生存及无主动脉事件生存上无差异。风险分析显示,近端破口最大径、胸主动脉最大直径和胸主动脉假腔最大直径对主动脉事件发生率有显著影响。
要点
- 1年和5年总生存率分别为94.0%和74.8%,无主动脉事件生存率分别为75.6%和58.7%。
- 腔内治疗与单纯药物治疗在1年和5年的全因生存及无主动脉事件生存上无差异。
- 近端破口最大径、胸主动脉最大直径和胸主动脉假腔最大直径对主动脉事件发生率有显著影响。
核心结论
- 对B型主动脉夹层患者积极管理可获得良好的长期生存,即使存在传统上认为与不良结局相关的特征。
- 所有患者均需终身密切监测,因为即使在接受腔内覆膜支架置入后,随访期间仍持续发生主动脉事件。
研究设计与样本
- 回顾性分析前瞻性收集的临床与CT影像数据,连续纳入11年间136例急性B型主动脉夹层患者。
- 比较接受腔内治疗(复杂型)与药物治疗(非复杂型)患者的特征。
- 采用Kaplan-Meier法估计累积总生存率及无主动脉事件生存率,并采用Cox比例风险模型探索相关因素。
主要发现
- 平均随访51个月(1-132个月),期间发生33例死亡和48例主动脉事件。
- 1年和5年总生存率分别为94.0%和74.8%,无主动脉事件生存率分别为75.6%和58.7%。
- 腔内治疗与单纯药物治疗患者在1年和5年的全因生存及无主动脉事件生存上无差异。
- 近端破口最大径、胸主动脉最大直径和胸主动脉假腔最大直径对主动脉事件发生率有显著影响。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate, in patients with acute type B aortic dissection, the results of medical and endovascular treatment in a large single centre experience and to investigate the clinical and imaging features on presentation that relate to poor outcome. METHODS: This was a retrospective analysis of prospectively collected clinical and CT imaging data. Consecutive patients (136) with acute type B aortic dissection were included in the study over an 11 year period. The characteristics of patients receiving endovascular (complicated) or medical treatment (uncomplicated) were compared. Kaplan-Meier estimators were used to estimate cumulative overall survival and survival free of aortic events. Factors associated with overall and aortic event free survival were also explored using Cox proportional hazards models. RESULTS: The mean follow up was 51 months (1-132), during which time 33 deaths and 48 aortic events occurred. At one and five years, overall survival was 94.0% and 74.8%, respectively, and freedom from aortic events was 75.6% and 58.7%. There was no difference in all cause survival and aortic event free survival at one and five years between the patients treated endovascularly and those receiving medical treatment alone. Risk analysis for aortic events demonstrated the maximum size of the proximal entry tear, the maximum thoracic aortic diameter, and the thoracic aortic false lumen maximum diameter to have a significant effect on the incidence of aortic events. CONCLUSIONS: Active management of patients with type B aortic dissection results in good long-term survival even in the presence of features traditionally associated with adverse outcomes. All patients require close lifetime surveillance as aortic events continue to occur during follow up even after endografting.
引用
- Clough RE, Barillà D, Delsart P, et al. Editor's Choice - Long-term Survival and Risk Analysis in 136 Consecutive Patients With Type B Aortic Dissection Presenting to a Single Centre Over an 11 Year Period. Eur J Vasc Endovasc Surg. 2018. PMID: 30293887. doi:10.1016/j.ejvs.2018.08.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。